Etanercept (Neurokine Pharmaceuticals)

依那西普（Neurokine Pharmaceuticals）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEtanercept (Neurokine Pharmaceuticals)

Drug Alias NameNP-1NK-001

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar

Mechanisms of ActionTumor necrosis factor β inhibitorsTumor necrosis factor α inhibitors

TargetsTumor necrosis factor βTumor necrosis factor α

Therapy Area/IndicationsCognition Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCognition Disorders

Inactive IndicationsN/A

ATC CodeL04AB01